07:00 , Jul 12, 2004 |  BioCentury  |  Strategy

Incubating a Company

Minding the Seed Gap Incubating a Company One way of solving the tech transfer problem may be to incubate actual companies, although few academic institutions have the wherewithal to take on this task. One such...
07:00 , Sep 25, 2000 |  BC Week In Review  |  Company News

TissueInformatics management update

TissueInformatics Inc., Pittsburgh, Penn.   Business: Enabling technology   Hired: J. Mark Braughler as SVP of business development, formerly president and CEO of Argonex Inc.  ...
08:00 , Feb 7, 2000 |  BC Week In Review  |  Company News

Argonex, Wyeth-Lederle Vaccines deal

Argonex will isolate, identify and sequence peptides expressed on Chlamydia pneumoniae-infected cells. Wyeth will evaluate the peptides for use in developing vaccines, and Argonex will receive research funding and potential royalties. Argonex Inc., Charlottesville, Va....
08:00 , Feb 3, 2000 |  BC Extra  |  Company News

Argonex and Wyeth-Lederle in Chlamydia deal

Argonex (Charlottesville, Va.) and Wyeth -Lederle Vaccines will indentify antigens associated with Chlamydia pneumoniae for the development of vaccines. Argonex will identify peptides expressed on Chlamydia-infected cells, and Wyeth -Lederle will evaluate the peptides. Argonex...
08:00 , Dec 13, 1999 |  BC Week In Review  |  Company News

Argonex board of directors update

(Management, B7; financing, B16) Argonex Inc., Charlottesville, Va.   Business: Cancer   Retired: William Battle as chairman, while remaining a director; Sheridan Snyder, formerly CEO, becomes chairman   Appointed: Harold Werner, managing director of Healthcare...
08:00 , Dec 13, 1999 |  BC Week In Review  |  Company News

Argonex management update

(Board, B7; financing, B16) Argonex Inc., Charlottesville, Va.   Business: Cancer   Transition: Mark Braughler becomes CEO while remaining president, replacing Sheridan Snyder who becomes chairman  ...
07:00 , Aug 16, 1999 |  BC Week In Review  |  Company News

Argonex Inc, Rohm and Haas Co. deal

The companies formed a joint venture, RHeoGene LLC (Charlottesville), to develop Rohm and Haas's ligand induced gene expression technology for mammalian gene therapy applications. Rohm and Haas will own a majority of RHeoGene and will...
07:00 , Aug 16, 1999 |  BC Week In Review  |  Company News

Argonex cancer, autoimmune/inflammation, infectious diseases news

Argonex will provide $2.5 million to establish subsidiary Argonex Discovery Ltd. (Dundee, Scotland), which will manufacture products used in high throughput screening research in cancer and infectious and autoimmune diseases, based on technology licensed exclusively...
07:00 , Oct 19, 1998 |  BC Week In Review  |  Company News

Argonex management update

Argonex Inc., Charlottesville, Va.   Business: Cancer, Supply/Service   Hired: J. Mark Braughler as president, formerly VP of business development at Pharmacia & Upjohn; and Ramila Philip as VP of immunology and clinical affairs, formerly...
07:00 , Aug 3, 1998 |  BioCentury  |  Emerging Company Profile

Arogonex Inc.

Argonex Inc. Charlottesville, Va. Technology: Antigen identification for immunotherapy Disease focus: Cancer Clinical status: Phase I/II Founded: 1994 by Sheridan Snyder Corporate partners: None University collaborators: Duke University, M.D. Anderson Cancer Center, University of Pittsburgh...